Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (451-460 of 473) with videos related to

Pageof 48
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in WomenSuzanne J Baron, Josephine C Chou, Tayyab Shah, et al.
Circulation|April 14, 2004
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trialAlexandra J Lansky, Ricardo A Costa, Gary S Mintz, et al.
The American Journal of Cardiology|December 10, 2008
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary arteryKenichi Tsujita, Akiko Maehara, Gary S Mintz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter RegistrySamit M Shah, Jennifer A Tremmel, Timothy D Henry, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
Circulation|April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical TrialAlexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
BMC Medicine|December 24, 2025
Three vs 12-month DAPT after implantation of biodegradable-polymer sirolimus-eluting coronary stent: a randomised clinical trialHongbo Yang, Feng Zhang, Xiwen Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2023
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trialAlexandra J Lansky, Bo Xu, Andreas Baumbach, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III SubstudyKush P Patel, Alexandra J Lansky, Dean J Kereiakes, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 48

Showing results (451-460 of 473) with videos related to

Sort By:
Pageof 48
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in WomenSuzanne J Baron, Josephine C Chou, Tayyab Shah, et al.
Circulation|April 14, 2004
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trialAlexandra J Lansky, Ricardo A Costa, Gary S Mintz, et al.
The American Journal of Cardiology|December 10, 2008
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary arteryKenichi Tsujita, Akiko Maehara, Gary S Mintz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter RegistrySamit M Shah, Jennifer A Tremmel, Timothy D Henry, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
Circulation|April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical TrialAlexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
BMC Medicine|December 24, 2025
Three vs 12-month DAPT after implantation of biodegradable-polymer sirolimus-eluting coronary stent: a randomised clinical trialHongbo Yang, Feng Zhang, Xiwen Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2023
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trialAlexandra J Lansky, Bo Xu, Andreas Baumbach, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III SubstudyKush P Patel, Alexandra J Lansky, Dean J Kereiakes, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 48